China's Ministry of Commerce (MOFCOM), in joint consultation with the Ministry of Science and Technology, officially published draft revisions to the nation's dual-use export control catalog on November 10, 2026, proposing comprehensive export restrictions on frontier large-scale artificial intelligence models and advanced biomanufacturing platforms. The regulatory authorities opened an official public consultation period scheduled to run through November 15, 2026, establishing standardized compliance protocols intended to safeguard sovereign scientific data security and strategic industrial leadership.
Thresholds target AI models over 10^26 FLOPS
The proposed restrictions establish quantitative computational and architecture thresholds designed to evaluate next-generation multimodal artificial intelligence foundations.
Under the draft annex, regulatory licensing requirements apply to advanced frontier foundational models trained using cumulative computational workloads exceeding 10^26 floating-point operations (FLOPS), alongside dense neural architectures incorporating more than two trillion operational parameters. Addressing industrial delegates during a press briefing, a senior MOFCOM technology export control official stated: "Administering transparent export controls across emerging dual-use technologies aligns with accepted international governance practices. Updating this catalog establishes a predictable regulatory framework that channels frontier technological advancement toward peaceful commercial applications while safeguarding vital national security interests."
The control framework further encompasses specialized distributed training compilation algorithms and automated model compression routines critical to large-scale cluster execution.
Biomanufacturing platforms added to controlled export categories
Beyond computational machine learning assets, the proposed catalog revisions incorporate advanced cellular and genetic engineering platforms into controlled categories. Targeted biomanufacturing sectors include high-throughput gene-editing vectors, autologous and allogeneic cellular therapy processing workflows, and synthetic humanized enzyme synthesis platforms. Domestic commercial enterprises and academic research institutions transferring underlying intellectual property, cell banks, or production know-how to foreign entities will be required to obtain statutory dual-use export licenses prior to execution.
Trade policy analysts observed that the targeted thresholds balance national technological sovereignty with ongoing global scientific engagement. Commercial entities across pharmaceutical biotechnology and artificial intelligence research are adjusting governance structures to guarantee full regulatory compliance.
International technology policy scholars and multilateral trade compliance specialists observed that publishing transparent quantitative thresholds for frontier artificial intelligence and cellular biotechnology establishes predictable governance norms for high-tech industries. Because next-generation neural foundation models and advanced genetic synthesis tools possess profound dual-use implications, establishing statutory administrative licensing frameworks safeguards critical sovereign technological capabilities from unregulated cross-border transfers. Intellectual property attorneys and corporate regulatory compliance officers emphasized that establishing streamlined licensing fast-tracks for academic research and international humanitarian healthcare partnerships ensures continued global collaboration. Industry analysts concluded that integrating comprehensive export governance with ongoing commercial innovation supports sustainable technological advancement.
Analysts say clear export rules support global collaboration
Emerging technology governance specialists and global research policy analysts highlighted that establishing objective regulatory boundaries fosters responsible scientific advancement while safeguarding public security interests. Because boundary-pushing artificial intelligence platforms and advanced synthetic biology systems exhibit rapid innovation cycles, adaptive administrative frameworks ensure technological oversight keeps pace with scientific capabilities. International scientific bodies commended transparent public consultation processes, reiterating that collaborative international dialogue remains essential for guiding frontier technologies toward ethical global applications.
High-tech trade associations and artificial intelligence research institutions emphasized that well-defined export compliance standards support sustainable technological progress. By establishing clear regulatory expectations, research organizations can responsibly navigate cross-border scientific partnerships while protecting sovereign intellectual assets and promoting safe international technology development. Technology governance councils and scientific research bodies emphasized that clear and predictable administrative procedures support academic collaboration while ensuring that strategic technological innovations remain properly aligned with public security standards. Moreover, international economic analysts noted that transparent regulatory standards provide international trade partners with greater legal certainty, facilitating responsible cooperation across global technology supply networks. Such adaptive regulatory measures ensure that technological development remains both commercially vibrant and strictly aligned with responsible global governance norms.
